Tea Gegenava MD.

• 1993-2000 – Tbilisi Medical Academy, department of general medicine;
• 2001 – State Medical Academy of Postgraduate Education. Training cycle program on clinical cardiology;
• 2004 – A full theoretical and practical training course on emergency medical services provided by the BLS, ALS, BTLS & ATLS program “Emergency Medical Services during the Prehospital Phase” (EMS Training Center);
• 2005 – Georgian State Medical Academy. Training cycle program on clinical echocardiography;
• 2011 – 5-month subspecialty program in echocardiography of the Institute of Postgraduate Medical Education and Continuous Professional Development of TSMU at Jo-Ann Medical Center.

• 2000-2011- Nodar Kipshidze National Center of Therapy, cardiologist;
• 2000-2004 – Emergency medical service “Kveli”, doctor;
• 2007-2009 – The European Network for Prevention and Health Promotion (EUROPREV) project: “EUROPREVIEW PATIENT STUDY – Attitudes to preventive services and to lifestyle: The views of patients”. Researcher;
• 2011-2015 – Medical center Junona, cardiologist, echocardiographist;
• 2015-2022– K. Eristavi National Center of Surgery, cardiologist, echocardiographist;
• 2018-present – Cardiologist, echocardiographist of the Open Heart Clinic.
• Since 2022 – till now – Head of Clinical and Interventional Cardiology of Ghudushauri Medical Center

• 2000 – Unified in the state certification examination: “General Practitioner – Attending Physician”. Licensed;
• 2004 – Unified in the state certification examination: “Cardiology”. Licensed;
• 2011-2004-present – Unified in the state certification examination: “Echocardiography”. Licensed.

• Member of the Georgian Society of Internists;
• 2004-present – Member of the International Society of Internal Medicine;
• 2004-present – Member of the Georgian International Society of Cardiomyopathy;
• 2004-present – Member of the Society of Cardiologists of Georgia;
• 2010-present – Member of the European Society of Cardiology.

1. Evaluation of additional efficiency and safety of early treatment with ezetimibe on the background of atorvastatin therapy in acute coronary syndrome. Cardiology and Internal Medicine XXI, achievements and challenges. 2010; 3-4: 9-13 (Co-auth.: N. Kipshidze, K. Nadaraia).
2. Effectiveness and safety of dual inhibition by Ezetimibe and Statins in high risk patients with primary hypercholesterolemia. Allergology and Immunology 2010; 11(2):163-165. (Co-auth.: N. Kipshidze, K. Nadaraia).
3. Gender peculiarities of modern treatment approach to Dyslipidemia. First International Conference “HEALTHY WOMEN”. Tbilisi, Georgia, June 18-19, 2009. Oral presentation and abstract. (Co-auth: N.N. Kipshidze, K.A. Nadaraia).
4. The effect of the Atorvastatin on the progression of atherosclerosis in young patients with metabolic syndrome. Allergology and Immunology 2010; 11(2):147-149. (Co-auth.: T.B. Gamezardashvili, N.N. Kipshidze, T.V. Talakvadze, L.N. Vakhtangishvili, T.A. Gegenava).

Georgian – Native
Russian – Fluent
English – Fluent